Theoretical foundations and practical applications of within-cycle correction methods

Medical Decision Making

Volumn 36, Issue 1, 2016, Pages 115-131

  Elbasha, Elamin H ^a   Chhatwal, Jagpreet ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

continuous time; discrete time; half cycle correction; numerical integration; state transition models

Indexed keywords

ALGORITHM; COST BENEFIT ANALYSIS; DECISION MAKING; ECONOMIC MODEL; HUMAN; MARKOV CHAIN; OUTCOME ASSESSMENT; PROCEDURES; THEORETICAL MODEL;

ALGORITHMS; COST-BENEFIT ANALYSIS; DECISION MAKING; HUMANS; MARKOV CHAINS; MODELS, ECONOMIC; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84950149120     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X15585121     Document Type: Article

References (22)

1. Siebert U, Alagoz O, Bayoumi AM, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Making. 2012; 32: 690-700.
2. Briggs A, Claxton K, Sculpher M,. Decision Modeling for Health Economic Evaluation. Oxford (UK): Oxford University Press, 2006.
3. Sonnenberg FA, Beck JR,. Markov models in medical decision making: a practical guide. Med Decis Making. 1993; 13: 322-31.
4. Sonnenberg FA, Wong JB,. Fine-tuning Markov models for life-expectancy calculations. Med Decis Making. 1993; 13: 170-2.
5. Barendregt JJ,. The half-cycle correction: banish rather than explain it. Med Decis Making. 2009; 29: 500-2.
6. Wisløff T,. Half-cycle correction and Simpson's method tested in different health economic models-does it matter which method we use? Abstract presented at: 33rd Annual Meeting of the Society for Medical Decision Making; 22-26 Oct 2011; Chicago, IL.
7. Naimark DM, Bott M, Krahn M,. The half-cycle correction explained: two alternative pedagogical approaches. Med Decis Making. 2008; 28: 706-12.
8. Naimark DM, Kabboul NN, Krahn MD,. The half-cycle correction revisited: redemption of a kludge. Med Decis Making. 2013; 33: 961-70.
9. Barendregt JJ,. The life table method of half cycle correction: getting it right. Med Decis Making. 2014; 34: 283-5.
10. Naimark DM, Kabboul NN, Krahn MD,. Response to "The Life Table Method of Half-Cycle Correction: Getting It Right.". Med Decis Making. 2014; 34: 286-7.
11. Chhatwal J, Elbasha EH,. Transformation of transition rates and probabilities in discrete-time Markov chains: what about competing risks? Abstract presented at: 33rd Annual Meeting of the Society for Medical Decision Making; 22-26 Oct 2011; Chicago, IL.
12. Welton NJ, Ades AE,. Estimation of Markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration. Med Decis Making. 2005; 25: 633-45.
13. Davis PJ, Rabinowitz P,. Methods of Numerical Integration. 2nd ed. New York: Academic Press; 1984.
14. Gail MH,. Encyclopedia of Epidemiologic Methods. New York: John Wiley & Sons; 2000.
15. Anderson RN,. Method for constructing complete annual U.S. life tables. Vital Health Stat 2. 2000;(129): 1-28.
16. Beck JR, Pauker SG,. The Markov process in medical prognosis. Med Decis Making. 1983; 3: 419-58.
17. Briggs A, Sculper M,. An introduction to Markov modeling for economic evaluation. Pharmacoeconomics 1998; 13: 397-409.
18. Chhatwal J, Ferrante SA, Brass C, et al. Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States. Value Health. 2013; 16: 973-86.
19. Jäkel A, Plested M, Dharamshi K, Modha R, Bridge S, Johns A,. A systematic review of economic evaluations in second and later lines of therapy for the treatment of non-small cell lung cancer. Appl Health Econ Health Policy. 2013; 11: 27-43.
20. van Rosmalen J, Toy M, O'Mahony JF,. A mathematical approach for evaluating Markov models in continuous time without discrete-event simulation. Med Decis Making. 2013; 33: 767-79.
21. Kulkarni VG,. Modeling and analysis of stochastic systems. New York: Chapman & Hall; 1995.
22. Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB,. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Making. 2012; 32: 733-43.